TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $16.48M2017: $26.12M2018: $30.43M2019: $43.10M2020: $57.99M2021: $33.05M2022: $52.12M2023: $36.27M2024: $57.88M2025: $67.67M$67.67M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$67.67M+16.9%
2024$57.88M+59.6%
2023$36.27M-30.4%
2022$52.12M+57.7%
2021$33.05M-43.0%
2020$57.99M+34.5%
2019$43.10M+41.6%
2018$30.43M+16.5%
2017$26.12M+58.5%
2016$16.48M—